PuriCore PLC
http://www.puricore.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From PuriCore PLC
Troubled Realm Therapeutics Selling Assets, Delisting From London AIM
US-based, UK-listed biotech says it is talking with 'interested parties' including those considering making an offer for the business.
Realm Reaches End of The Road And Seeks Buyer
The US company listed in the UK has been devastated by the failure of its investigational eczema drug in Phase II trials in August and has hired an advisor to look for strategic alternatives, including a sale.
New Ways to Attack Atopic Dermatitis: Realm Expects POC Next Quarter
Realm Therapeutics is evaluating a substance derived from insights into innate immunity that has potential as an immunomodulator in various dermatological disorders, including atopic dermatitis and acne, with proof-of-concept (POC) expected in the third quarter.
Deals Shaping The Medical Industry, July/August 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced May and June 2014.
Company Information
- Industry
- Services
-
Medical Devices
- Infection Control-Sterilization
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice